Expertise in
6
conditions

Dr. Raymund R. Razonable

Infectious Disease
Rochester, MN 
Accepting New Patients
Expertise in
6
conditions
Rochester, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Raymund Razonable is an Infectious Disease provider in Rochester, Minnesota. Dr. Razonable is highly rated in 6 conditions, according to our data. His top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Knee Replacement. Dr. Razonable is currently accepting new patients.

His clinical research consists of co-authoring 283 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Infectious Disease
Licenses
Internal Medicine in WI
Hospital Affiliations
Mayo Clinic Hospital Rochester
Languages Spoken
English
Filipino
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Sanford Health
  • HMO
  • PPO
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS

Locations

MAYO CLINIC
Rochester, MN 55902
Other Locations
MAYO CLINIC
200 1st St Sw, Rochester, MN 55905

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Renal Transplantation in Adults: A Prospective, Single-Arm, Multi-Center Clinical Trial
Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Renal Transplantation in Adults: A Prospective, Single-Arm, Multi-Center Clinical Trial
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2025
Intervention Type: Biological, Other, Procedure
Study Drug: Recombinant Human Papillomavirus Nonavalent Vaccine
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants
Enrollment Status: Terminated
Publish Date: July 24, 2023
Intervention Type: Drug
Study Drug: Casirivimab+Imdevimab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
Prophylaxis Versus Preemptive Therapy for the Prevention of CMV in High-Risk R-D+ Liver Transplant Recipients
Prophylaxis Versus Preemptive Therapy for the Prevention of CMV in High-Risk R-D+ Liver Transplant Recipients
Enrollment Status: Completed
Publish Date: August 26, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials

283 Total Publications

Unveiling the Unforeseen.
Unveiling the Unforeseen.
Journal: The New England journal of medicine
Published: March 05, 2025
Similar Doctors
Larry M. Baddour
Expertise in
5
conditions
Dr. Larry M. Baddour
Infectious Disease
Expertise in
5
conditions
Dr. Larry M. Baddour
Infectious Disease
200 1st St Sw, 
Rochester, MN 
 (0.8 mi)
507-284-2511
Languages Spoken:
English

Larry Baddour is an Infectious Disease provider in Rochester, Minnesota. Dr. Baddour is highly rated in 5 conditions, according to our data. His top areas of expertise are Endocarditis, Infective Endocarditis, Sepsis, Coronary Artery Bypass Graft (CABG), and Aortic Valve Replacement.

Expertise in
4
conditions
Dr. Elie F. Berbari
Infectious Disease
Expertise in
4
conditions
Dr. Elie F. Berbari
Infectious Disease

Mayo Clinic

200 1st St Sw, 
Rochester, MN 
 (0.8 mi)
507-284-2511
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Elie Berbari is an Infectious Disease provider in Rochester, Minnesota. Dr. Berbari is highly rated in 4 conditions, according to our data. His top areas of expertise are Osteomyelitis, Infectious Arthritis, Severe Acute Respiratory Syndrome (SARS), Hip Replacement, and Knee Replacement. Dr. Berbari is currently accepting new patients.

Expertise in
5
conditions
Dr. Douglas R. Osmon
Infectious Disease
Expertise in
5
conditions
Dr. Douglas R. Osmon
Infectious Disease

Mayo Clinic

200 1st St Sw, 
Rochester, MN 
 (0.8 mi)
507-284-2511
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Douglas Osmon is an Infectious Disease provider in Rochester, Minnesota. Dr. Osmon is highly rated in 5 conditions, according to our data. His top areas of expertise are Infectious Arthritis, Osteomyelitis, Osteomyelitis in Children, Knee Replacement, and Hip Replacement. Dr. Osmon is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Razonable's expertise for a condition
ConditionClose
View All 32 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile